Comments
Loading...

OrthoPediatrics Analyst Ratings

KIDSNASDAQ
Logo brought to you by Benzinga Data
Consensus Rating1
Buy
Highest Price Target1
$52.00
Lowest Price Target1
$24.00
Consensus Price Target1
$38.30

OrthoPediatrics Analyst Ratings and Price Targets | NASDAQ:KIDS | Benzinga

OrthoPediatrics Corp has a consensus price target of $38.3 based on the ratings of 10 analysts. The high is $52 issued by BTIG on October 4, 2023. The low is $24 issued by Truist Securities on April 11, 2025. The 3 most-recent analyst ratings were released by Piper Sandler, Needham, and Truist Securities on May 8, 2025, May 8, 2025, and April 11, 2025, respectively. With an average price target of $32 between Piper Sandler, Needham, and Truist Securities, there's an implied 39.43% upside for OrthoPediatrics Corp from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Dec 24
1
Jan
2
Mar
2
Apr
2
May
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.9
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Piper Sandler
Needham
Truist Securities
Lake Street
Citizens Capital Markets

1calculated from analyst ratings

Analyst Ratings for OrthoPediatrics

Buy NowGet Alert
05/08/2025Buy Now30.72%Piper Sandler
Matt O'Brien53%
$40 → $30MaintainsOverweightGet Alert
05/08/2025Buy Now83.01%Needham
Mike Matson57%
$42 → $42ReiteratesBuy → BuyGet Alert
04/11/2025Buy Now4.58%Truist Securities
Richard Newitter74%
$26 → $24MaintainsHoldGet Alert
04/09/2025Buy Now83.01%Needham
Mike Matson57%
$42 → $42ReiteratesBuy → BuyGet Alert
04/07/2025Buy Now61.22%Lake Street
Ben Haynor37%
→ $37Initiates → BuyGet Alert
03/21/2025Buy Now117.86%Citizens Capital Markets
David Turkaly52%
$50 → $50ReiteratesMarket Outperform → Market OutperformGet Alert
03/05/2025Buy Now39.43%Stifel
Rick Wise74%
$40 → $32MaintainsBuyGet Alert
03/05/2025Buy Now83.01%Needham
Mike Matson57%
$42 → $42ReiteratesBuy → BuyGet Alert
01/14/2025Buy Now83.01%Needham
Mike Matson57%
$42 → $42ReiteratesBuy → BuyGet Alert
12/18/2024Buy Now8.93%Truist Securities
Richard Newitter74%
$28 → $25MaintainsHoldGet Alert
11/08/2024Buy Now83.01%Needham
Mike Matson57%
$42 → $42ReiteratesBuy → BuyGet Alert
10/14/2024Buy Now22%Truist Securities
Richard Newitter74%
$34 → $28MaintainsHoldGet Alert
09/13/2024Buy Now48.15%Truist Securities
Richard Newitter74%
$30 → $34ReiteratesHold → HoldGet Alert
09/13/2024Buy Now117.86%JMP Securities
David Turkaly52%
$50 → $50ReiteratesMarket Outperform → Market OutperformGet Alert
09/13/2024Buy Now83.01%Needham
Mike Matson57%
$42 → $42ReiteratesBuy → BuyGet Alert
08/16/2024Buy Now83.01%Needham
Mike Matson57%
$42 → $42ReiteratesBuy → BuyGet Alert
08/08/2024Buy Now30.72%Truist Securities
Richard Newitter74%
$35 → $30ReiteratesHold → HoldGet Alert
07/16/2024Buy Now52.51%Truist Securities
Samuel Brodovsky68%
$38 → $35MaintainsHoldGet Alert
05/08/2024Buy Now65.58%Truist Securities
Samuel Brodovsky68%
$35 → $38MaintainsHoldGet Alert
05/07/2024Buy Now117.86%JMP Securities
David Turkaly52%
$50 → $50ReiteratesMarket Outperform → Market OutperformGet Alert
05/07/2024Buy Now83.01%Needham
Mike Matson57%
$37 → $42MaintainsBuyGet Alert
04/10/2024Buy Now61.22%Needham
Mike Matson57%
$37 → $37ReiteratesBuy → BuyGet Alert
03/27/2024Buy Now74.29%Piper Sandler
Matt O'Brien53%
→ $40ReiteratesOverweight → OverweightGet Alert
03/08/2024Buy Now39.43%Truist Securities
Samuel Brodovsky68%
$31 → $32MaintainsHoldGet Alert
03/07/2024Buy Now61.22%Needham
Mike Matson57%
$37 → $37ReiteratesBuy → BuyGet Alert
03/07/2024Buy Now117.86%JMP Securities
David Turkaly52%
$50 → $50ReiteratesMarket Outperform → Market OutperformGet Alert
03/07/2024Buy Now48.15%Stifel
Rick Wise74%
$32 → $34MaintainsBuyGet Alert
01/25/2024Buy Now35.08%Truist Securities
Kaila Krum70%
$39 → $31DowngradeBuy → HoldGet Alert
12/22/2023Buy Now69.93%Truist Securities
Richard Newitter74%
$35 → $39MaintainsBuyGet Alert
12/07/2023Buy Now117.86%JMP Securities
David Turkaly52%
$60 → $50MaintainsMarket OutperformGet Alert
11/08/2023Buy Now52.51%Truist Securities
Richard Newitter74%
$31 → $35MaintainsBuyGet Alert
11/07/2023Buy Now61.22%Needham
Mike Matson57%
$55 → $37MaintainsBuyGet Alert
10/04/2023Buy Now126.58%BTIG
Ryan Zimmerman71%
$59 → $52MaintainsBuyGet Alert
09/01/2023Buy Now161.44%JMP Securities
David Turkaly52%
→ $60ReiteratesMarket Outperform → Market OutperformGet Alert
08/02/2023Buy Now122.22%Truist Securities
Richard Newitter74%
$57 → $51MaintainsBuyGet Alert
08/01/2023Buy Now161.44%JMP Securities
David Turkaly52%
→ $60ReiteratesMarket Outperform → Market OutperformGet Alert
08/01/2023Buy Now139.65%Needham
Mike Matson57%
→ $55ReiteratesBuy → BuyGet Alert
05/02/2023Buy Now139.65%Needham
Mike Matson57%
$51 → $55MaintainsBuyGet Alert
05/02/2023Buy Now161.44%JMP Securities
David Turkaly52%
→ $60Reiterates → Market OutperformGet Alert
04/17/2023Buy Now122.22%Needham
Mike Matson57%
→ $51MaintainsBuyGet Alert
04/17/2023Buy Now148.37%Truist Securities
Richard Newitter74%
$53 → $57MaintainsBuyGet Alert
03/01/2023Buy Now122.22%Needham
Mike Matson57%
$50 → $51MaintainsBuyGet Alert
01/31/2023Buy Now144.01%Truist Securities
Richard Newitter74%
$47 → $56MaintainsBuyGet Alert
01/10/2023Buy Now117.86%Stifel
Rick Wise74%
$52 → $50MaintainsBuyGet Alert
11/02/2022Buy Now161.44%JMP Securities
David Turkaly52%
$70 → $60MaintainsMarket OutperformGet Alert
11/01/2022Buy Now117.86%Needham
Mike Matson57%
$59 → $50MaintainsBuyGet Alert
10/17/2022Buy Now126.58%Truist Securities
Kaila Krum70%
$66 → $52MaintainsBuyGet Alert
08/05/2022Buy Now187.58%Truist Securities
Kaila Krum70%
$51 → $66MaintainsBuyGet Alert
07/18/2022Buy Now165.8%BTIG
Ryan Zimmerman71%
$65 → $61MaintainsBuyGet Alert
07/18/2022Buy Now117.86%Stifel
Rick Wise74%
$57 → $50MaintainsBuyGet Alert

FAQ

Q

What is the target price for OrthoPediatrics (KIDS) stock?

A

The latest price target for OrthoPediatrics (NASDAQ:KIDS) was reported by Piper Sandler on May 8, 2025. The analyst firm set a price target for $30.00 expecting KIDS to rise to within 12 months (a possible 30.72% upside). 18 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for OrthoPediatrics (KIDS)?

A

The latest analyst rating for OrthoPediatrics (NASDAQ:KIDS) was provided by Piper Sandler, and OrthoPediatrics maintained their overweight rating.

Q

When was the last upgrade for OrthoPediatrics (KIDS)?

A

There is no last upgrade for OrthoPediatrics

Q

When was the last downgrade for OrthoPediatrics (KIDS)?

A

The last downgrade for OrthoPediatrics Corp happened on January 25, 2024 when Truist Securities changed their price target from $39 to $31 for OrthoPediatrics Corp.

Q

When is the next analyst rating going to be posted or updated for OrthoPediatrics (KIDS)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of OrthoPediatrics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for OrthoPediatrics was filed on May 8, 2025 so you should expect the next rating to be made available sometime around May 8, 2026.

Q

Is the Analyst Rating OrthoPediatrics (KIDS) correct?

A

While ratings are subjective and will change, the latest OrthoPediatrics (KIDS) rating was a maintained with a price target of $40.00 to $30.00. The current price OrthoPediatrics (KIDS) is trading at is $22.95, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch